drugset / Trial / NCT01707953

Efficacy of Midodrine for the Prevention of Orthostatic Hypotension During Early Mobilization After Fast-track Hip Arthroplasty

NCT01707953

Phase 3 Completed 120 enrolled Rigshospitalet, Denmark
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The aim of this study is to examine the efficacy of 5 mg Midodrine (Gutron) vs. placebo on reducing the incidence of orthostatic hypotension during mobilization 6 h after a total hip arthroplasty.

Timeline

Start
2012-10
Primary completion
2013-09
Completion
2013-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Midodrine Small molecule 5 mg